Department of Anatomical, Histological, Forensic and Orthopaedic Sciences, Sapienza University of Rome, Rome, Italy.
Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):892-902. doi: 10.26355/eurrev_201901_16904.
Women suffering from Uterine Factor Infertility (UFI) arising from congenital conditions (e.g., Rokitansky-Kuster-Hauser syndrome) or hysterectomy can fulfill their wish to achieve motherhood only by resorting to surrogacy, which is, however, banned in most countries. Medical research has long been looking into uterus transplant (UTx), which may constitute a valuable alternative for such patients. Following decades of animal testing and clinical trials, several successful pregnancies have been carried to term. Yet UTx is still to be considered as an experimental procedure. The report's authors believe UTx has the potential to become a mainstream surgical practice, but for the time being, several ethical issues need to be weighed in before it does.
因先天性疾病（如罗基坦斯基-库斯特-豪泽综合征）或子宫切除术而患有子宫因素不孕（Uterine Factor Infertility，UFI）的女性，只有通过代孕才能实现生育愿望，但代孕在大多数国家都是被禁止的。医学研究长期以来一直在研究子宫移植（Uterus Transplant，UTx），这可能为这些患者提供了一种有价值的选择。经过几十年的动物试验和临床试验，已经有几例成功妊娠至足月。然而，UTx 仍被视为一种实验性手术。报告的作者认为，UTx 有可能成为一种主流的手术实践，但目前，在实施之前，需要权衡一些伦理问题。
